Circassia Initiates Phase II Trials Of Novel Grass And Ragweed Allergy Therapies And Advances Phase III Plans For Cat Allergy T-Cell Vaccine
Links shared publicly online about this topic.
- 833total visits
Circassia Initiates Phase II Trials Of Novel Grass And Ragweed Allergy Therapies And Advances Phase III Plans For Cat Allergy T-Cell Vaccine
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced that it has further advanced the clinical development of three of its leading T-cell allergy vaccines.' In recent
View full resource at medicalnewstoday.com
Tags: Vaccination, Allergies, Cat Allergy, Pet, Vaccine, Cat
Most Recently Shared on October 1, 2010 at 9:05 pm By:
Circassia Initiates Phase II Trials Of Novel Grass And Ragweed Allergy Therapies And Advances Phase III Plans For Cat ... http://mnt.to/3KCJ
Also Shared By:
Advertisement
MNT Allergy News
@mnt_allergy
Circassia Initiates Phase II Trials Of Novel Grass And Ragweed Allergy Therapies And Advances Phase III Plans For Cat ... http://mnt.to/3KCJ
1 year ago...